Myofibroblasts in the accessory ligament (distal check ligament) and the deep digital flexor tendon of foals.

This research article is focused on the study of a specific cell type called myofibroblasts in the accessory ligament and deep digital flexor tendon of healthy foals. The findings highlight the potential role of these cells in flexure contracture of these tendons and suggest the prospect of utilizing tetracycline as a potential treatment for foal joint flexure deformity.

Research Methodology

• The researchers utilized tissue specimens from 25 foals that were necropsied for reasons unrelated to musculoskeletal disease or this particular study.
• Specific tissues for examination were the distal check ligament and deep digital flexor tendon of the forelimbs of these foals.
• The examination technique used was histology, the study of the microscopic structure of tissues.
• The presence of myofibroblasts was determined through immunohistochemical staining, a method that uses antibodies to detect specific proteins—in this case alpha-smooth muscle actin (alpha-SMA), which is a characteristic protein of myofibroblasts.

Results of the Research

• The majority of the cells identified in the distal check ligament and the deep digital flexor tendon of all the foals stained positive for alpha-SMA. This indicates a high prevalence of myofibroblasts in these tissues.
• The fact that myofibroblasts, which possess the ability to contract, were predominant in these tissues suggests their potential role in flexure contracture of these tendons.

Conclusions and Implications

• The study provides valuable insight into the cellular composition of equine tendons, particularly the high prevalence of myofibroblasts in healthy foal tendon tissues.
• The potential of these cells in causing contractures in these tendons is significant, considering their contractile abilities.
• The study also muses on the potential use of tetracycline, a type of antibiotic, as a therapeutic option to manage foals’ joint flexure deformity. Tetracycline has the capacity to bind calcium or decrease the expression of the contractile protein alpha-SMA, which could inhibit the contractile abilities of myofibroblasts.
• While the potential therapeutic use of tetracycline is speculative at this stage, it does provide an innovative standpoint for future research.